Schistosomal Sulfotransferase Interaction with Oxamniquine Involves Hybrid Mechanism of Induced-fit and Conformational Selection

Curr Comput Aided Drug Des. 2020;16(4):451-459. doi: 10.2174/1573409915666190708103132.

Abstract

Background: Sulfotransferase family comprises key enzymes involved in drug metabolism. Oxamniquine is a pro-drug converted into its active form by schistosomal sulfotransferase. The conformational dynamics of side-chain amino acid residues at the binding site of schistosomal sulfotransferase towards activation of oxamniquine has not received attention.

Objective: The study investigated the conformational dynamics of binding site residues in free and oxamniquine bound schistosomal sulfotransferase systems and their contribution to the mechanism of oxamniquine activation by schistosomal sulfotransferase using molecular dynamics simulations and binding energy calculations.

Methods: Schistosomal sulfotransferase was obtained from Protein Data Bank and both the free and oxamniquine bound forms were subjected to molecular dynamics simulations using GROMACS-4.5.5 after modeling it's missing amino acid residues with SWISS-MODEL. Amino acid residues at its binding site for oxamniquine was determined and used for Principal Component Analysis and calculations of side-chain dihedrals. In addition, binding energy of the oxamniquine bound system was calculated using g_MMPBSA.

Results: The results showed that binding site amino acid residues in free and oxamniquine bound sulfotransferase sampled different conformational space involving several rotameric states. Importantly, Phe45, Ile145 and Leu241 generated newly induced conformations, whereas Phe41 exhibited shift in equilibrium of its conformational distribution. In addition, the result showed binding energy of -130.091 ± 8.800 KJ/mol and Phe45 contributed -9.8576 KJ/mol.

Conclusion: The results showed that schistosomal sulfotransferase binds oxamniquine by relying on hybrid mechanism of induced fit and conformational selection models. The findings offer new insight into sulfotransferase engineering and design of new drugs that target sulfotransferase.

Keywords: Sulfotransferase; binding energy; conformational selection; induced-fit; oxamniquine; protein data bank.

MeSH terms

  • Animals
  • Humans
  • Molecular Docking Simulation
  • Molecular Dynamics Simulation
  • Oxamniquine / metabolism
  • Oxamniquine / pharmacology*
  • Prodrugs / metabolism
  • Prodrugs / pharmacology*
  • Schistosoma / chemistry
  • Schistosoma / drug effects
  • Schistosoma / enzymology*
  • Schistosoma / metabolism
  • Schistosomiasis / drug therapy
  • Schistosomiasis / parasitology
  • Schistosomicides / metabolism
  • Schistosomicides / pharmacology*
  • Sulfotransferases / chemistry
  • Sulfotransferases / metabolism*

Substances

  • Prodrugs
  • Schistosomicides
  • Oxamniquine
  • Sulfotransferases